Imperative Care, Inc. announced findings from a subanalysis of patients with M2 occlusions enrolled in the Imperative Trial ...

The Motley Fool. DATE Wednesday, July 16, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...

Donald Trump's swollen ankles have sparked fresh concerns about his health, with a doctor now warning that it could be a sign ...

A team of leading infectious disease scientists from academia and industry have been awarded £17.9 million to identify new ...

The Pulsed Field Ablation Industry is valued at USD 1.6 million in 2025. It is expected to grow at a CAGR of 24.2% and reach ...

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Imperative Care today announced study data evaluating aspiration with its Zoom system in stroke patients with M2 occlusions.

Momentum in Johnson & Johnson’s cardiovascular business continues, while the company looks to regain its footing in the ...